Thyroid Cancer Clinical Trials in Houston, Texas
10 recruitingHouston, Texas
Showing 1–10 of 10 trials
Recruiting
Phase 2
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Neoadjuvant TreatmentThyroid Cancer
M.D. Anderson Cancer Center45 enrolled1 locationNCT06959511
Recruiting
Phase 1
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
MelanomaThyroid CancerGlioma
Pfizer124 enrolled77 locationsNCT05538130
Recruiting
Phase 2
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled4 locationsNCT06458036
Recruiting
Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
Cultural AdaptationMedullary Thyroid Cancer (MTC)
M.D. Anderson Cancer Center40 enrolled1 locationNCT07142005
Recruiting
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Radiofrequency AblationPapillary Thyroid CancerLow Risk
M.D. Anderson Cancer Center50 enrolled1 locationNCT07140757
Recruiting
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Thyroid Cancer
M.D. Anderson Cancer Center459 enrolled1 locationNCT06507878
Recruiting
Phase 1
SLV-154 Treatment of Metastatic Solid Tumors
Breast Cancer MetastaticOvarian CancerEndometrial Cancer+7 more
Solve Therapeutics70 enrolled9 locationsNCT06771219
Recruiting
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Pediatric CancerPapillary Thyroid CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia32 enrolled9 locationsNCT05024929
Recruiting
Phase 2
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled5 locationsNCT05783323
Recruiting
Phase 2
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Thyroid CancerThyroid CarcinomaPapillary Thyroid Cancer+3 more
Massachusetts General Hospital30 enrolled6 locationsNCT05668962